UPDATED – 2022 Safety Protocols
CHI has instituted mandatory health and safety protocols for all in-person participants. We are excited to bring our community back together in 2022, with trust and safety as our top priorities. All in-person participants are required to:
Bringing Together Vector Engineers and Scientists to Accelerate Gene Therapy Development
The past five years have been a critical turning point for gene therapy. From the first approved oligonucleotide-based therapy to the success of CAR-T cell therapies, followed by the recent in-vivo gene therapies and the emerging gene editing strategies, these gene therapeutics are not only life-changing for patients with rare diseases, but are also laying the foundation for potential treatments of other unmet medical needs.
Given the highly dynamic and competitive nature of the gene therapy industry, scientists are facing a multitude of challenges as they move from bench to clinic. This event thus hopes to gather the knowledge and expertise of scientists in vector engineering, analytics, immunogenicity assessments, preclinical development and clinical translation, to help accelerate next generation gene therapy development.
Become a Sponsor or Exhibitor
Whether you’re targeting the entire conference community of life sciences, pharmaceutical, clinical, healthcare, and IT professionals, a topic-specific community, a specific individual, or high-level decision makers, we offer a variety of methods to access our esteemed delegates. Explore our sponsor or exhibitor packages which offer a wide range of platforms to launch products, gain exposure, collect feedback, network and generate new leads.
2022 KEYNOTE SPEAKERS
Potency Assay Development and Validation for Gene Therapy Products
Lyndi Rice, PhD
Head, QC Viral Vectors, Biomarin
AAV Capsid Engineering to Increase Human Tissue Tropism and Transduction
Matthias Hebben, PhD
Global Vice President, Technology Development, LogicBio Therapeutics Inc.
Gene Therapy for Young Onset PD: Focus on the Small to Go Big
Jennifer Johnston, PhD
Co-Founder & CEO, NysnoBio
Join Our Growing Community of Scientists & Engineers
Senior Conference Director
PARTNERING & SPONSORSHIP
Manager, Business Development
Sr. Manager, Business Development
MEDIA & ASSOCIATION
Director of Product Marketing